| GlaxoSmithKline
Consumer Healthcare Q3 '05 PAT up by 34 %
Gurgaon, October 21, 2005: GlaxoSmithKline
Consumer Healthcare Limited (GSKCH), a global
nutritional healthcare company present in India
since 1958, today declared its financial results
for quarter ended September 30, 2005. Sales
stood at Rs. 290.6 crores for the quarter,
representing growth of 9.1 %. For the quarter,
PAT rose 34 % to Rs. 30.3 crores and PBT grew
27.7 % to Rs. 46.5 crores. "The increase in
PAT has been driven by a strong sales
performance supported by the company's
comprehensive cost containment programme",
said Nick Massey, Managing Director,
GlaxoSmithKline Consumer Healthcare Ltd. "Our
focus on consumer-centric innovation is doing
well. The recent launch of new Horlicks Lite has
been the first of its kind in India. This launch
offers the consumers two products; a health
drink and a biscuit. Both of these combine great
taste with the goodness of a special formulation
to meet the dietary needs of health conscious
adults." The company also declared an interim
dividend of 80 %. For the nine months ended
September 30, 2005, sales stood at Rs. 820.6
crores, 10.6 % over last year. For this period,
PBT stood at Rs. 128.1 crores and PAT at Rs.
85.7 crores, 33.4 % and 41.3 % over 2004 levels.
_________________________________________________________________________
About GlaxoSmithKline Consumer Healthcare Ltd.
GSKCH, which was established in 1958, is an
associate of GlaxoSmithKline plc. of the U.K, a
global science based healthcare company. GSKCH
has continually benefited from the technical and
marketing inputs that have been available as a
consequence of this association. GSKCH is one of
the largest players in the health food drinks
industry. The Company with its manufacturing
plants located in Nabha, Rajahmundry and Sonepat
has a total workforce of about 2700 people.
GSKCH has a strong marketing and distribution
network in India comprising over 1800
wholesalers and direct coverage of over 4,50,000
retail outlets. Its flagship product, Horlicks,
is a widely regarded and highly respected brand
for over 100 years. The Company also
manufactures and markets Boost, Viva and Maltova
and in addition markets and distributes a number
of products in diverse categories, which include
prominent household names such as Eno, Crocin
and Iodex.
GSKCH has a strong marketing and distribution
network in India comprising over 1800
wholesalers and direct coverage of over 4,50,000
retail outlets. Its flagship product, Horlicks,
is a widely regarded and highly respected brand
for over 100 years. The Company also
manufactures and markets Boost, Viva and Maltova
and in addition markets and distributes a number
of products in diverse categories, which include
prominent household names such as Eno, Crocin
and Iodex.
|
